eScholarship
metadata only
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis
BACKGROUND: Progressive fibrosing interstitial lung disease (ILD) is characterised by parenchymal scar formation, leading to high morbidity and mortality. The ability to predict this phenotype remains elusive. We conducted a proteomic analysis to identify novel plasma biomarkers of progressive fibro
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Risk factors for idiopathic pulmonary fibrosis: an umbrella review of meta-analyses and mendelian randomization analyses.#1134756
- Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease#828183
- Proteomic Discovery of Urinary Myoglobin as a Noninvasive Biomarker for PROCHOB caused by CUBN Variants#146514
- Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants#898535
- Proteomic Discovery of Urinary Myoglobin as a Noninvasive Biomarker for PROCHOB caused by <i>CUBN</i> Variants#149873
Record · ID 1174825
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive